Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells
Reduced SIRT2 deacetylation and increased p300 acetylation activity leads to a concerted mechanism of hyperacetylation at specific histone lysine sites (H3K9, H3K14, and H3K18) in castration-resistant prostate cancer (CRPC). We examined whether circulating tumor cells (CTCs) identify patients with a...
Saved in:
Published in | Oncotarget Vol. 14; no. 1; pp. 738 - 746 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Impact Journals LLC
20.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!